Evidence map›Paper›PMID 32093622›Full record

ArticleBMC bioinformatics2020

MOMO - multi-objective metabolic mixed integer optimization: application to yeast strain engineering.

Ricardo Andrade, Mahdi Doostmohammadi, João L Santos, Marie-France Sagot, Nuno P Mira, Susana Vinga

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ricardo AndradeERABLE European Team, INRIA, Rhône-Alpes, France.
Mahdi DoostmohammadiIDMEC, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
João L SantosInstitute for Bioengineering and Biosciences, Instituto Superior Técnico, Department of Bioengineering, Universidade de Lisboa, Lisbon, Portugal.
Marie-France SagotERABLE European Team, INRIA, Rhône-Alpes, France.
Nuno P MiraInstitute for Bioengineering and Biosciences, Instituto Superior Técnico, Department of Bioengineering, Universidade de Lisboa, Lisbon, Portugal. nuno.mira@ist.utl.pt.
Susana VingaIDMEC, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal. susanavinga@tecnico.ulisboa.pt.ORCID http://orcid.org/0000-0002-1954-5487

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn this paper, we explore the concept of multi-objective optimization in the field of metabolic engineering when both continuous and integer decision variables are involved in the model. In particular, we propose a multi-objective model that may be used to suggest reaction deletions that maximize and/or minimize several functions simultaneously. The applications may include, among others, the concurrent maximization of a bioproduct and of biomass, or maximization of a bioproduct while minimizing the formation of a given by-product, two common requirements in microbial metabolic engineering.

resultsProduction of ethanol by the widely used cell factory Saccharomyces cerevisiae was adopted as a case study to demonstrate the usefulness of the proposed approach in identifying genetic manipulations that improve productivity and yield of this economically highly relevant bioproduct. We did an in vivo validation and we could show that some of the predicted deletions exhibit increased ethanol levels in comparison with the wild-type strain.

conclusionsThe multi-objective programming framework we developed, called MOMO, is open-source and uses POLYSCIP (Available at http://polyscip.zib.de/). as underlying multi-objective solver. MOMO is available at http://momo-sysbio.gforge.inria.fr.

Indexed as

SoftwareBiomassEthanolMetabolic EngineeringModels, BiologicalSaccharomyces cerevisiaeEthanolMetabolic EngineeringOptimizationSystems Biology

Identifiers

PMID32093622
PMCPMC7041195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.